<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1"><url><loc>https://www.ophthallogix.com/archive</loc><changefreq>daily</changefreq></url><url><loc>https://www.ophthallogix.com/about</loc><changefreq>weekly</changefreq></url><url><loc>https://www.ophthallogix.com/p/china-rewrites-its-drug-pricing-rules</loc><lastmod>2026-04-24</lastmod><changefreq>monthly</changefreq></url><url><loc>https://www.ophthallogix.com/p/chinas-medical-device-listing-is</loc><lastmod>2026-04-21</lastmod><changefreq>monthly</changefreq></url><url><loc>https://www.ophthallogix.com/p/when-guidance-becomes-mandate-what</loc><lastmod>2026-04-18</lastmod><changefreq>monthly</changefreq></url><url><loc>https://www.ophthallogix.com/p/china-iol-reimbursement-landscape</loc><lastmod>2026-04-18</lastmod><changefreq>monthly</changefreq></url><url><loc>https://www.ophthallogix.com/p/the-three-reimbursement-regimes-hiding</loc><lastmod>2026-04-18</lastmod><changefreq>monthly</changefreq></url><url><loc>https://www.ophthallogix.com/p/china-eye-care-procurement-ecosystem</loc><lastmod>2026-04-18</lastmod><changefreq>monthly</changefreq></url></urlset>